Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ocular vasospasm. 4: Clinical examples].

A Prünte-Glowazki1, J Flammer

  • 1Universitäts-Augenklinik Basel.

Klinische Monatsblatter Fur Augenheilkunde
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leber's Hereditary Optic Neuropathy, Normal Tension Glaucoma, and Flammer Syndrome: Long Term Follow-up of a Patient.

Klinische Monatsblatter fur Augenheilkunde·2017
Same author

[Phenomenology and Clinical Relevance of the Flammer Syndrome].

Klinische Monatsblatter fur Augenheilkunde·2016
Same author

Unexpected Effect of Calcium Channel Blockers on the Optic Nerve Compartment Syndrome.

Klinische Monatsblatter fur Augenheilkunde·2016
Same author

The effect of hypoxia on intra-ocular, mean arterial, retinal venous and ocular perfusion pressures.

Clinical hemorheology and microcirculation·2015
Same author

Search for lepton flavour violation in the <i>eμ</i> continuum with the ATLAS detector in [Formula: see text]<i>pp</i> collisions at the LHC.

The European physical journal. C, Particles and fields·2015
Same author

[Dysphotopsia due to a manufacturing error in an intraocular lens].

Klinische Monatsblatter fur Augenheilkunde·2014
Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026
See all related articles

Ocular vasospasms cause various symptoms. Treating these vasospasms with medication can significantly improve visual field defects, even in patients with normal-tension glaucoma.

Area of Science:

  • Ophthalmology
  • Neurology

Background:

  • Ocular vasospasms are presumed to cause a range of visual symptoms.
  • Understanding the clinical manifestations and effective treatments for ocular vasospasms is crucial.

Observation:

  • Two distinct cases of patients experiencing symptoms attributed to ocular vasospasms are presented.
  • The first patient exhibited a visual field defect, particularly under psychological stress.
  • The second patient had normal-tension glaucoma.

Findings:

  • Pharmacological intervention successfully alleviated visual field defects in the patient experiencing stress-induced symptoms.
  • Targeted treatment addressing vasospasm led to a marked improvement in the visual field of the patient with normal-tension glaucoma.

Related Experiment Videos

Implications:

  • This study highlights the significant impact of ocular vasospasms on visual function.
  • Effective management of vasospasms can lead to substantial visual field recovery.
  • The findings suggest that vasospasm treatment should be considered in patients with unexplained visual field defects, including those with normal-tension glaucoma.